Inventor · disambiguated record
Georg Winter
Also filed as: WINTER GEORG
18 granted patents·7 pending applications·415 citations·filing 2015–2022
95Inventor score
Files withDANA FARBER CANCER INST INC21CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH2CEMM FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH1PROXYGEN GMBH1
Top patents by PatentIndex Score
25 records- 0198US10464925B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 5, 2019·36 cites·16 claims
- 0298US10125114B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2017·Granted Nov 13, 2018·57 cites·20 claims
- 0398US9821068B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2016·Granted Nov 21, 2017·71 cites·117 claims
- 0498US9770512B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 26, 2017·63 cites·42 claims
- 0598US9750816B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 5, 2017·62 cites·56 claims
- 0698US9694084B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 4, 2017·76 cites·84 claims
- 0797US10849980B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 1, 2020·16 cites·45 claims
- 0897US10669253B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2018·Granted Jun 2, 2020·17 cites·19 claims
- 0996US11583586B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2020·Granted Feb 21, 2023·3 cites·21 claims
- 1091US11311609B2Regulating chimeric antigen receptorsDANA FARBER CANCER INST INC·Filed 2018·Granted Apr 26, 2022·6 cites·29 claims
- 1190US11059801B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2020·Granted Jul 13, 2021·2 cites·22 claims
- 1286US11046954B2Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responsesDANA FARBER CANCER INST INC·Filed 2018·Granted Jun 29, 2021·2 cites·17 claims
- 1386US10899768B2Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Jan 26, 2021·3 cites·19 claims
- 1484US11578075B2Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2020·Granted Feb 14, 2023·1 cites·17 claims
- 1574US2022135967A1Tunable endogenous protein degradationDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1674US2023131952A1Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1771US2018085465A1Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1871US2021301286A1Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responsesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1968US11293023B2Tunable endogenous protein degradationDANA FARBER CANCER INST INC·Filed 2018·Granted Apr 5, 2022·0 cites·13 claims
- 2055US10925868B2Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Feb 23, 2021·0 cites·19 claims
- 2153US2023241226A1Compounds for targeted degradation of carrier proteins and uses thereofCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2020·Application pending·0 cites
- 2250US2024132485A1Heterocyclic cullin ring ubiquitin ligase compounds and uses thereofCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2021·Application pending·0 cites
- 2348US12023385B2Tunable endogenous protein degradation with heterobifunctional compoundsDANA FARBER CANCER INST INC·Filed 2018·Granted Jul 2, 2024·0 cites·24 claims
- 2442US12410152B2Oxazole and thioazole-type cullin ring ubiquitin ligase compounds and uses thereofPROXYGEN GMBH·Filed 2020·Granted Sep 9, 2025·0 cites·18 claims
- 2534US2021293788A1Method for identifying a chemical compound or agent inducing ubiquitination of a protein of interestCEMM FORSCHUNGSZENTRUM FUR MOLEKULARE MEDIZIN GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Georg Winter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →